Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Aug 25, 2016 $2.19 $2.19 $1.99 $2.09 72 200
Aug 24, 2016 $2.06 $2.24 $2.06 $2.10 8 400
Aug 23, 2016 $2.10 $2.24 $2.05 $2.12 5 400
Aug 22, 2016 $2.13 $2.17 $2.06 $2.07 50 600
Aug 19, 2016 $2.32 $2.32 $2.13 $2.18 6 400
Aug 18, 2016 $2.19 $2.30 $2.14 $2.14 16 000
Aug 17, 2016 $2.24 $2.24 $2.13 $2.19 2 800
Aug 16, 2016 $2.33 $2.35 $2.06 $2.14 76 700
Aug 15, 2016 $2.54 $2.64 $2.32 $2.32 13 300
Aug 12, 2016 $2.52 $2.60 $2.41 $2.60 5 600
Aug 11, 2016 $2.48 $2.48 $2.38 $2.41 4 100
Aug 10, 2016 $2.55 $2.55 $2.34 $2.40 15 500
Aug 09, 2016 $2.56 $2.64 $2.46 $2.49 36 500
Aug 08, 2016 $2.30 $2.68 $2.30 $2.51 68 300
Aug 05, 2016 $2.26 $2.44 $2.26 $2.38 20 600
Aug 04, 2016 $2.37 $2.37 $2.32 $2.34 1 900
Aug 03, 2016 $2.39 $2.40 $2.37 $2.37 800
Aug 02, 2016 $2.42 $2.46 $2.20 $2.40 60 600
Aug 01, 2016 $2.40 $2.50 $2.40 $2.48 5 800
Jul 29, 2016 $2.45 $2.47 $2.41 $2.47 6 300
Jul 28, 2016 $2.40 $2.52 $2.40 $2.52 4 300
Jul 27, 2016 $2.41 $2.49 $2.35 $2.49 2 500
Jul 26, 2016 $2.41 $2.45 $2.31 $2.38 7 200
Jul 25, 2016 $2.52 $2.52 $2.27 $2.34 20 600
Jul 22, 2016 $2.43 $2.50 $2.43 $2.47 800
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT